Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
LFST · against 211 other Healthcare companies of similar size
Ranked #41 of 212 · scores higher than 81% of peers
Bars: peers in each 10-point band of the growth score28 peers with a growth score of 80–89, including LFST · Click a bar to see the companies
Mainly thanks to its earnings per share growth, 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | LFST | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 211 reported | 20.4% | 9.4% | 75% | 33% | |
| Earnings per share growthHigher is better · 134 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 204 reported | 18.2% | 9.0% | 78% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 2.8B USD | 99 | 51 | |
| 5 | 37.3B HKD (≈$4.8B) | 98 | 90 | |
| 34 | 7.0B USD | 89 | 57 | |
| 38 | 4.3B USD | 88 | 69 | |
| 38 | 4.6B USD | 88 | 61 | |
| 40 | 936.1B JPY (≈$6.4B) | 86 | 80 | |
| 41 | 5.1B USD | 85 | 52 | |
| 42 | 23.0B CNY (≈$3.2B) | 84 | 64 | |
| 42 | 3.9B USD | 84 | 47 | |
| 42 | 40.3B SEK (≈$4.0B) | 84 | 79 | |
| 42 | 4.6B USD | 84 | 65 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score